Rapid attainment of target trough concentrations of tacrolimus for early improvement of clinical symptoms in patients with ulcerative colitis-Reference-Cited by-同舟云学术

Rapid attainment of target trough concentrations of tacrolimus for early improvement of clinical symptoms in patients with ulcerative colitis

Published:2019-01-02 Issue:3 Volume:44 Page:409-414
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Yamada Yuto¹²,Ohno Yuta¹³,Niwa Takashi¹^ORCID,Kato‐Hayashi Hiroko¹,Hayashi Hideki²⁴,Ibuka Takashi⁵,Araki Hiroshi⁵,Sugiyama Tadashi²⁴,Shimizu Masahito⁴,Suzuki Akio¹

Affiliation:

1. Department of Pharmacy Gifu University Hospital Gifu Japan

2. Laboratory of Pharmacy Practice and Social Science Gifu Pharmaceutical University Gifu Japan

3. Department of Pharmacology Asahi University School of Dentistry Gifu Japan

4. Community Healthcare Pharmacy Gifu Pharmaceutical University Gifu Japan

5. Department of Gastroenterology Gifu University Graduate School of Medicine Gifu Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.12800

Reference21 articles.

1. Inflammatory Bowel Disease

3. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

4. FK506, An Immunosuppressant Targeting Calcineurin Function

5. A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in research of tacrolimus for treatment of inflammatory bowel disease;World Chinese Journal of Digestology;2019-07-08